Association of mutations in the hemochromatosis gene with shorter life expectancy

Archives of Internal Medicine

Volumn 161, Issue 20, 2001, Pages 2441-2444

  Bathum, Lise ^a   Christiansen, Lene ^a   Nybo, Hanne ^b   Ranberg, Karen Andersen ^b   Gaist, David ^b   Jeune, Bernard ^b   Petersen, Niels Erik ^a   Vaupel, James ^b,c,d   Christensen, Kaare ^b,d  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c MAX PLANCK INSTITUTE FOR DEMOGRAPHIC RESEARCH   (Germany)

^d DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; AGED; ARTICLE; DISEASE ASSOCIATION; EXON; FEMALE; GENE FREQUENCY; GENE MUTATION; GENOTYPE; HEMOCHROMATOSIS; HETEROZYGOTE; HUMAN; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCREENING TEST; TWINS;

EID: 0035851274     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.161.20.2441     Document Type: Article

References (31)

1. Hereditary haemochromatosis: To screen or not
2. Evolving expression of hereditary hemochromatosis
3. A survey of 2851 patients with haemochromatosis: Symptoms and response to treatment
4. A novel MHC class I - Like gene is mutated in patients with hereditary haemochromatosis
5. Mutation analysis in hereditary hemochromatosis
6. Haemochromatosis and HLA-H
7. Haemochromatosis, HFE and genetic complexity
8. HFE mutation analysis in 711 hemochromatosis probands: Evidence for S65C implication in mild form of hemochromatosis
9. Prevalence of C282Y and H63D mutations in the hemochromatosis (HFE) gene in the United States
10. High incidence of the Cys282Tyr mutation in the HFE gene in the Irish population: Implications for haemochromatosis
11. The significance of haemochromatosis gene mutations in the general population: Implications for screening
12. Prevalence of the C282Y and H53D mutations in the HFE gene in patients with hereditary haemochromatosis and in control subjects from northern Germany
13. Determination of gene frequencies for two common haemochromatosis mutations in the Danish population by a novel polymerase chain reaction with sequence-specific primers
14. Global prevalence of putative haemochromatosis mutations
15. Hereditary haemochromatosis should be more widely known about
16. Clinical implications of the hemochromatosis gene
17. Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda
18. Increased risk of acute myocardial infarction in carriers of the hemochromatosis gene Cys282Tyr mutation
19. Heterozygosity for a hereditary hemochromatosis gene is associated with cardiovascular death in women
20. Iron: Metabolism, toxicity and therapy
21. Antioxidant status and lipid peroxidation in hereditary haemochromatosis
22. Estimation of apolipoprotein E genotype-specific relative mortality from the distribution of genotypes in centenarians and middle-aged men: Apolipoprotein E gene is a "frailty gene," not a "longevity gene."
23. The Danish 1905 Cohort: A genetic-epidemiological nationwide survey
24. Genetic and environmental influences on functional abilities among Danish twins aged 75 years and older
25. Strength and anthropometric measures in identical and fraternal twins: No evidence of masculinization of females with male co-twins
26. Declining physical abilities with age: A cross-sectional study of older twins and centenarians in Denmark
27. Denaturent gradient gel electrophoresis analysis of the hemochromatosis (HFE) gene: Impact of HFE gene mutations on the manifestation of porphyria cutanea tarda
28. Age, body mass index, and functional illness
29. Family history as a risk factor for primary cardiac arrest
30. Heterozygous hemochromatosis as a risk factor for premature myocardial infarction